This essay has been submitted by a student. This is not an example of the work written by our professional essay writers.
Cellular senescence is the barriers that protecting our cells from undergoing abnormal proliferation. However, there are many factors that can induce the cellular senescence such as, DNA damage and telomere shortening ( Campisi J, 2005) . Study by Dr. Leonard Hayflick and Dr. Paul Moorhead, showed that human cells have a limited capacity to grow in culture by dividing. They showed that, human cells derived from newborn tissue, embryonic and fetal can divide from 40 to 60 times, but then can't divide more than that. However, the number of cell divisions is called Hayflick Limit ( Maity and Koumenis,2006).
Nowadays, scientists believe that the determination of the Hayflick Limit is the length of human telomeres. Telomeres are the end part of chromosomes. When the cell divides, it must to double its chromosomes. Results in each daughter cell have a full complement of genetic materials. When the cells double the chromosomes, in each time the chromosomes lose a little bit of its telomeres. After 40 to 60 times of cells divisions, the telomeres have reached a critically short length, the replication of chromosomes will stop and no longer cell dividing. So, the cells that have shortened telomeres and can't divide called senescent.
The end replication problem:
Several studies shows that, the process of semi-conservative replication of DNA works only in the 5' to 3' direction, and the DNA polymerase needs binding with an RNA primer. (Smeal et al., 2007) Scientists predicated the characteristic of the consequences of DNA replication and they termed it the end-replication problem. However, the loss of a small 5' nucleotide segment because of the DNA synthesis took place and with repeated replication the telomere become shorter.
Telomeres and telomerase:
Telomeres are located at the end of liner chromosomes, and are composed of repetitive DNA sequences. There are 92 telomeres in humans because 23 chromosomes and in each end of each chromosome one telomeres. Hence, each human telomere has thousands of repeats of the six nucleotide sequence, TTAGGG. The hypothesis of aging and cancer based on the telomere-telomerase shows that most human somatic cells don't have telomerase activity, whereas most human tumours have telomerase activity. However, the balance between the end-replication problem and telomerase maintained the telomere length. Telomerase can be defining as a cellular reverse transcriptase (a ribonucleoprotein enzyme complex) which is referred to as a cellular immortalizing enzyme. It maintains the telomere length by adding hexameric (TTAGGG) repeats onto the end of the chromosomes. Telomerase has ability to reinstate lost telomeri DNA- repeat sequence, which can help cells to bypass replicative senescence and may confer cellular immortality. (Beitzinger et al., 2006) There is evidence that replicative senescence of human cells is due to telomere shortening. (Vijji et al., 2007)
The two crucial constituents of telomerase consist of two enzymes, a human telomerase reverse transcriptase (hTERT) and an RNA template molecule which has a complimentary to the human telomeric DNA (hTR). However, hTERT is the primary rate-limiting component of telomerase, and hTR can be limiting for telomere maintenance. Telomerase is protecting germ line cells against telomere shortening. Studies show that, telomeres of human germ line cells are maintained at about 15 kbp. In contrast, in most somatic cells that undergo more than 40-80 times of cellular replicative senescence, telomerase is not expressed in these cells, with the considering of telomere shorting. Whereas, the expression and activity of telomerase in tumours cells and transformed cells is very high. (Vincent et al., 1992; Koji et al., 2001)
Aging and Telomeresy
Telomeres are the regulator that regulates the number of cell division. However, normal somatic human cells have a limited capacity to divide, while the tumour cells can divide forever. Studies show that, the telomeric sequences become shorter after each DNA replicates. So, the cells stop dividing (senescent) when the telomere reaches a critically short length. However, when the telomerase introduced into human cells result in maintain a normal chromosome complement.
Senescence provoked by oxidative stress. Several studies shows that, the reactive oxygen species in endothelial cells produced from intracellular or extracellular origin, which can stimulate the growth of senescence by acting at multiply sub-cellular levels. As mentioned above, telomeres are mainly damaged by oxidation. Furthermore, telomerase is inhibited by oxidative damage which lead to effect directly or indirectly in telomeres. However, ROS can stimulate senescence by telomere-independent mechanisms. Finlay, this reaction will damage the DNA and mitochondria. In addition, it may also activate sytosolic response kinases or other redox-sensitive signalling proteins, which are produced in senescence responses.
However, over mutagenic stimulation by acceleration of activated oncogenes has been shown to stimulate senescence. This finding has been observed during the overproduction of Akt, Ras, or Racl activation. However, in this stage the stimulation of senescence is assumed as a result of dysfunction of the cellular redox-balance causing the overproduction of ROS, which may lead to induce p53 activity.
The Role of mitochondria:
Reaction oxygen species (ROS) may destroy the DNA and mitochondria, which may cause dysfunction of mitochondria. However, during normal respiration ROS is generated by mitochondria. Several studies illustrated that; ROS may affect the electron transport chain leading to increase the oxidative burden of the cell. Recently, the significance of mitochondria-derived ROS in the induction of cell senescence has been focused by a study investigating the function of prohibitin-1 (PHB1) in this process. PHB1 is a part of the inner mitochondrial membrane, and assume to be the vital part that maintains the normal mitochondrial function. This can explain that, the function of PHB1 in the cells stimulate mitochondria to generate ROS. Moreover, over production of ROS in mitochondria lead to oxidative destruction of cell components such as proteins, nucleic acids, and lipids.
Senescence and Apoptosis:
The final fate of senescent cells has pathophysiological disorders, due to altered phenotype. Several studies investigated the relation between senescence and apoptosis in endothelial cells. Study byWagner and his group, shows that, apoptosis is the final fate of senescent cells (Wagner et al., 2001). Whereas, other studies show that, senescent cells don't undergo apoptosis, but it may induce the sensitivity of these cells to apoptotic stimuli such as TNF-α and oxidized LDL (Hoffmann et al.,2001; Spyridopoulos et al.,2002) . However, this effect may attribute to, p53, p21, and p16 expression on the induction of apoptosis and senescence (Sharpless and DePinho ,2004).. The p53/p21 pathway is involved in apoptosis and senescence (Napolitano et al., 2007), while p16 pathway is only involved in senescence.
One of the important signals factors that stimulate senescence response is dysfunctional telomeres. However, there are many signals factors that may induce senescence response; such as: strong mitogenic signals, non-telemetric damage DNA, and chromatin perturbations.
Cells arrest growth in association to phenotype are not identifiable as different from replicatively senescent cells, when they provide medium high level of DNA damage, occurs. However, when they deal with agent or expose to mutation, which may damage normal chromatin complex. In addition, strong mitogenic or stress signals can enhance the cell to become senescent. There are many oncogenes that may induce the cell to become senescent such as activation of growth factor signalling like RAS or RAF.
All these persuaders of cellular senescence have a power to cause cancer. As result, chromatin perturbation, DNA damage, and release of oncogenes don't cause any change in normal cells, but inhence cells to arrest growth in association with a senescent phenotype. This may lead to cellular senescence.
Role of p53 and p16/pRBTumor-suppressior pathways:
Factors like, activated oncogenes and ionizing radition have been known to transform cells. These agents are involved after cell mutation, which may stimulate the senescence response. However, mutation by senescence leads to dysfunction of the genes encoding contents of the p53 or PRB tumor-suppressor pathways. Both, p53 and PRB are involved in the production of many cellular genes. However, P53 and PRB, each one of them has his pathway to stimulate senescence. The p53 pathways, results to DNA damage, even it may also response to nongenctoxic stress, and temprarly stop cell cycle progression by expression of p21. While p16 and PRB are basically induced by non genetic stress.
The senescent phenotype:
Cellular senescent involve several changes in gene expression. However, a few of which are essential for the growth arrest. Interestingly, senescent cells need two or three features that show senescent phenotypes, such as; irreversible of cell division, and in other cell types, resistance to signals that may lead to apoptotic cell death. It may also affect the cell functions.
However, the induction of senescence phenotype may lead to impediment to normal mitosis creating a mutation in the genetic material such as; genotoxin-induced premature senescence, cumulative DNA damage induced senescence, intrinsic ageing induced senescence (M1), and proliferate history dependent telomere attrition induced mitotic crisis (M2). (Roninoson et al., 2003)
B-Galactosidase is a common feature of senescent cells that is expressed as a natural (pH 6) and called the senescence-associated B-Galactosidase (SA-Bgal). SA-gal expressed in different senescent human cells types, such as: keratinocytes, fibrobalsts, mammary epithelial cells and adult melanocytes. Furthermore, SA-B gal induced by diverse senescence- inducing stimuli such as short telomeres. However, the assay of SA-gal is simple and commonly used as a marker for the senescent phenotype.
In the process of creation mammalian cells , antioxidant enzymes has developed to cooperate and remove ROS generation , which is generated under normal physiology conditions by aerobic metabolism. However, during these processes many enzymes are involved to enhance the reaction such as; catalase (CAT), glutathione reductase (GR), manganes superoxide dismutase (MnSOD), glutathione peroxidise (GPx), and copper/zinc superoxide dismutase (Cu/ZnSOD) (Beckman et al., 1998). The activation by Cu/ZnSOD and MnSOD lead to change the superoxide anions to H2O2. Then, the activation by GPx or CAT changes the H2O2 to water( Lee HC and Wei YH,2007). To protect a suitable redox status of the cells and to maintain the sulfhydry groups of proteins, GSH is used. GPx is used to generate oxidized glutathione, which is then reduced by GR to GSH. However, the association between proteins and anti-oxidant enzymes, together with other small-molecular -weight antioxidants, may remove ROS and free radicals under normal physiologic condition (Beckman et al.,1998). Whereas, the over generation of ROS may lead to destroy the antioxidant system and lead to DNA damage. Studies show that, most of the antioxidant enzymes are decreased with age expect MnSOD which is raise up to 65 years and then start to reduce (Lu et al., 1999). From these finding we can suggest that, oxidative stress increased by the decrease of antioxidant capacity and disorders in the expression of free radicals scavenging enzymes, which may lead to increase cells damage in the aging process.
DNA damage by oxidative agents may lead to changes the purine and pyrimidine bases sequences, breaks down of the single and double-strand of DNA, and reacts with other molecules. So many changes of nuclear DNA and mtDNA of tissue cells are raised with the age (Beckman et al., 1998). Thereafter, features of human mtDNA become highly influenced to cause cell injury. However, during these reaction several changes has happened such as, the reaction take place near to site of ROS generation from the respiratory chain, lack of prevention by histones, and limitation to repair DNA damage (Ames et al., 1993). It has been shown that, the progression of DNA polymerase is blocked by the damaged nucleotides, which is causing of decreased amplification of the target sequence (Yakes et al,. 1997).
Loss of telomere integrity:
Telomerase is an enzyme whose synthesised Telomeric DNA and this enzyme play a key role in detecting the starting of replicative senescence. However, telomeric DNA become shorter in case of absence or low expressed of telomerase during cell division. This phenomenon called telomere integrity, which is triggering senescence by trigger DNA damage checkpoints and then stop cell multiplication ( Kurz et al., 2004) ) . As mention above, the significant progressive oxidative damage of DNA resulting from the frequent contact of cellular contents to oxidative stress is one of the important processes that related to aging and age-related pathologies. However, studies on fibroblasts shows that oxidative stress may activate the growth of replicative senescence ( Kurz et al., 2004 ). This process called stress-induces premature senescence (Toussaint et al., 2000). Several studies show that, the starting point of senescence has been caused by accelerated telomere attrition, most likely resulting from the formation of single strand breaks in the telomere (von Zglinicki, 2002). Some other studies illustrated that; telomere damage may not attributed by stress-induced premature senescence (Chen et al., 2001; Toussaint et al., 2002). However, it is not clear why these differences are their between the studies. It may be of cell type, the type or level of oxidative used in the studies, the level of antioxidant protection and may be for some other experimental differences.
1.The G1/S control in cellular senescence:
pRb is a vital protector of cell cycle progression in eukaryotes. Ther are several factors that are regulate the activity of pRb, such as acetylation, ubiqitination and phosphorylation. However, the activity of pRb may creat a block on G1 progression that is developed by phosphorylation (Sherr and McCormick, 2002). Furthermore, a series of cyclin -dependent kinases (CDKs), CDK2, CDK4 and CDK6, play a vital function in the phosphorylation of pRb (Rowland and Bernards, 2006). When CDKs phosphorylated pRb , pRb lose its ability to join E2F/Dp transcription factor complexes, which may result in entry into S-phase of the cell cycle. The action of CDKs is inactivated in senescent cells due to release of CDK inhibitors. There are two main CDK inhibitors that are released by senescent cells such as, p21Cip1/Waf1/Sdi1 and P16NK4a. However, p21Cip1/Waf1/Sdi1 work to links between p53 pathway and Rb-pathway to provide a tight security network in the direction of tumour suppression (Gil, Peters G, 2006). Several studies indicated that, the regulation of p21Cip1/Waf1/Sdi1 expression has a vital role in processes like cellular senescence and DNA damage-induced cell cycle, which may prevent the cells to become carcinoma cell (Sherr and Roberts, 1999). p16INK4a is wok to inhibit the activation of D-type CDKs, CDK4 and CDK6. When the p16INK4a is binding to CDK4 and CDK6, it stimulates the redistribution of Cip/Kip family CDK inhibitors, P27Kip1 and P21Cip1/Waf1/Sid1, from cyclinD-CD4/6 to cyclinE-CDK2 complexes, causing inactivation of CDK2-kinase. Thereafter, the association between p16INK4a and p21Cip1/Waf1/Sdi1 prevent the phosphorylation of pRb, which result in stable G1 arrest in senescent cells (Gil and Peters, 2006) . Interestingly, the p16INK4a gene is recognized as a tumour suppressor gene because it is often inactivated in a wide range of human cancers. In addition, it may also participate with another tumour suppressor gene called p14ARF. Studies show that the mutation within this region only affects p16INK4a activity but not p14ARF activity. This finding suggests that, p16INK4a /Rb-pathway play a vital function in tumour suppression (Gil and Peters, 2006).
However, it is known that, the p16INK4a inactivate the pRb pathway, following the inactivation of pRb pathway induce the DNA synthesis but not cell proliferation, this happened if p16INK4a is ectopically released prior to inactivation of pRb in human cells. Whereas, inactivation of pRb is adequate to inactivate the p16INK4a effect, this is happened if pRb pathway is inactivated prior to p16INK4a expression (Gil and Peters, 2006). However, when p16INK4a activated pRb so pRb enhance another pathway which is irreversibly causes cell cycle arrest either in M or G2 phase. Moreover, poly-nucleated cells is gradually increase when the human cells inactivated by pRb and P53 and release high level of p16INK4a (Takahashi et al., 2006). This finding may explain that this mechanism may target cytokinesis. Studies using SVts8 cells indicated that, p16INK4a/ Rb pathway associate with mitogenic signals to stimulate irreversible cytokinetic block during the generation of reactive oxygen species (ROS) (Takahashi et al., 2006). It has been mention before that, the physiological function of the cells required ROS, but overproduction of ROS may lead to apoptosis or cellular senescence. In case of low stress, mitogenic signals inactivate pRb , which is then stimulate E2F/DP complexes to induce S-phase entry. E2F/DP activation reduces the amount of ROS (Takahashi et al., 2006). These finding shows that, the E2F/DP activity manage this reaction in proliferating normal human cells, even mitogenic signals have the power to generate ROS. Whereas, in case of high cellular stress, p16INK4a/Rb -pathway inactivate E2F/DP. So in this case, mitogenic signals stimulate the ROS production by activating PKCδ, which is a significant downstream mediator of the ROS signalling pathway.
Interestingly, when ROS and PKCδ activate ROS signalling pathway lead to the over generation of ROS, which may create a positive feedback loop to mainatain ROS- PKCδ signalling. In human senescent cells, maintained activation of ROS- PKCδ signaling permanently blocks cytokinesis by decreasing WARTS and a mitotic exit network (MEN) kinase, which are required for cytokinesis (Takahashi et al., 2006). This may lead to increase the level of p16INK4a and create an autonomous stimulation of ROS- PKCδ signalling, result in an irreversible block to cytokinesis in human senescent cells. However, this mechanism may act as a fail-safe mechanism, practically in case of the sudden inactivation of p53 and pRb in human senescent cells (Ramsey and Sharpless, 2006).
Ames BN, Shigenaga MK, Hagen TM.(1993). Oxidants, antioxidants, and the degenerative diseases of aging. Proc Natl Acad Sci U S A 90,7915-7922.
Beckman KB, Ames BN.(1998). The free radical theory of aging matures. Physiol Rev 78,547-581.
Beckman KB, Ames BN.(1998). The free radical theory of aging matures. Physiol Rev 78,547-581.
Campisi J.(2005). Senescent cells, tumor suppression, and organismal aging: Good citizens, bad neighbors. Cell 120:513-522.
Chen QM, Prowse K R, Tu VC, Purdom S,Linskens M H. (2001). Uncoupling the senescent phenotype from telomere shortening in hydrogen peroxide-treated fibroblasts. Exp. Cell Res. 265, 294-303.
Gil J, Peters G. (2006). Regulation of the INK4b-ARF-INK4a tumour suppressor locus: all for one or one for all.Nat Rev Mol Cell Biol 7(9),667-677.
Hoffmann J, Haendeler J, Aicher A, Rossig L, Vasa M, Zeiher AM, Dimmeler S.(2001). Aging enhances the sensitivity of endothelial cells toward apoptotic stimuli: important role of nitric oxide. Circ Res 89, 709-715.
Kurz DJ, Decary S, Hong Y, Trivier E, Akhmedov A, Erusalimsky JD.(2004). Chronic oxidative stress compromises telomere integrity and accelerates the onset of senescence in human endothelial cells. Journal of Cell Science 117, 2417-2426.
Lee HC, Wei YH.(2007). Oxidative Stress, Mitochondrial DNA Mutation, and Apoptosis in Aging. Eperimental Biology and Medicines 232, 592-606.
Lu CY, Lee HC, Fahn HJ, Wei YH.(1999). Oxidative damage elicited by imbalance of free radical scavenging enzymes is associated with large-scale mtDNA deletions in aging human skin. Mutat Res 423, 11-21.
Napolitano MA, Cipollaro M, Cascino A, Melone MA, Giordano A, Galderisi U. (2007). Brg1 chromatin remodeling factor is involved in cell growth arrest, apoptosis and senescence of rat mesenchymal stem cells. Journal of Cell Science 120, 2904-2911.
Rowland BD, Bernards R. (2006). Re-evaluating cell-cycle regulation by E2Fs.Cell 127(5),871-874.
Sharpless NE, DePinho RA.(2004). Telomeres, stem cells, senescence, and cancer. J. Clin. Invest. 113,160-168.
Sherr CJ, McCormick F. (2002). The RB and p53 pathways in cancer.Cancer Cell 2002, 2(2),103-112.
Spyridopoulos I, Isner JM, Losordo DW.(2002). Oncogenic ras induces premature senescence in endothelial cells: role of p21(Cip1/Waf1). Basic Res Cardiol 97, 117-124.
Toussaint O, Medrano E, von Zglinicki T. (2000). Cellular and molecular mechanisms of stress-induced premature senescence (SIPS) of human diploid fibroblasts and melanocytes. Exp. Gerontol. 35, 927-945.
ToussaintO, Remacle J, Dierick JF, Pascal T, Frippiat C, Zdanov S, Magalhaes JP, Royer V, Chainiaux F. (2002). From the Hayflick mosaic to the mosaics of ageing. Role of stress-induced premature senescence in human ageing. Int. J. Biochem. Cell Biol. 34, 1415-1429.
von Zglinicki, T. (2002). Oxidative stress shortens telomeres. Trends Biochem. Sci. 27, 339-344.
Wagner M, Hampel B, Bernhard D, Hala M, Zwerschke W, Jansen-Durr P.( 2001). Replicative senescence of human endothelial cells in vitro involves G1 arrest, polyploidization and senescence-associated apoptosis. Exp Gerontol 36,1327-1347.
Yakes FM, van Houten B.(1997). Mitochondrial DNA damage is more extensive and persists longer than nuclear DNA damage in human cells following oxidative stress. Proc NatlAcadSci U S A94,514-519.
Sherr CJ, Roberts JM. (1999). CDK inhibitors: positive and negative regulators of G1-phase progression.Genes Dev 13(12), 1501-1512.
Takahashi A, Ohtani N, Yamakoshi K, Iida S, Tahara H, Nakayama K, Nakayama KI, Ide T, Saya H, Hara E. (2006). Mitogenic signalling and the p16INK4a-Rb pathway cooperate to enforce irreversible cellular senescence.Nat Cell Biol 8(11), 1291-1297.
Ramsey MR, Sharpless NE.(2006). ROS as a tumour suppressor. Nat Cell Biol 8(11), 1213-1215.
Beitzinger M, Oswald C, Beinoraviciute-Kellner R. Stiewe T.(2006). Regulation of telomerase activity by the p53 family member p73. Journal of Oncogene 25, 813-826.
Koji I, Goberdhan D, Judith C. (2001). Regulation of cellular senescence by p53. European Journal of Biochemistry 268, 2784-2791.
Vincent J C, Robert J P, Mitch O R. (1992) .Molecular Changes with in Vitro Cellular Senescence. Aging and Cellular Defense Mechanism, 663, 187.
Roninson IB. (2003) .Tumour cell senescence in cancer treatment. Cancer Research, 163(11),2705-2715.
Jerry WS, Woodring EW. (2004). Senescence and immortalization: role of telomeres and telomerase. Carcinogenesis, 26(5), 301-510.
Viji M. Draviam, Frank Stegmeier, Grzegorz Nalepa, Mathew E. Sowa, Jing Chen, Anthony Liang, Gregory J. Hannon, Peter K. Sorger, J. Wade Harper and Stephen J. Elledge. (2007). A functional genomic screen identifies a role for TAO1 kinase in spindle-checkpoint signalling. Nature Cell Biology, 9, 556-564.